Tectonic Therapeutic Inc.

TECX | NASDAQ

Price Alert Chart Builder DCF Calculator

$26.50

-$0.13 (-0.49%)

At close: Sep 22, 2026, 4:00 PM ET

$26.13

-$0.37 (-1.40%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.49%

(1D)

Rating

Updated: Aug 17, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $500.03M

1D Range

26.23 27.60

52W Range

14.39 39.53

Valuation (TTM)

PE -5.83

PB 2.24

EV/EBITDA -3.34

Valuation (NTM)

Forward PE N/A

Forward PEG -1.02

Price Target $78

Cash Flow

FCF Yield -18.1%

SBC Adj. FCF Yield -21.7%

SBC Impact -20.2%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 39.0% | 51.6%

FCF 3Y | 5Y -36.4% | 2.5%

Returns

ROA -36.2%

ROE -35.3%

ROIC -41.6%

Financial Health

Net Cash

$222.67M

Current Ratio 22.29

Interest Coverage -2,373.13

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that re...

Sector Healthcare

Industry Biotechnology

Employees 60

IPO Date Jun 20, 2018

Website tectonictx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$78

Upside

+194.34%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞